lapatinib has been researched along with corticosterone in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 27,121 | 124 | 6,622 |
| Protein | Taxonomy | lapatinib (IC50) | corticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asari, Y; Daimon, M; Kageyama, K; Kogawa, H; Niioka, K; Sugiyama, A | 1 |
1 other study(ies) available for lapatinib and corticosterone
| Article | Year |
|---|---|
Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Corticosterone; Corticotrophs; Lapatinib; Mice; Mice, Nude; Neoplasm Transplantation; Protein Kinase Inhibitors | 2019 |